BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25440318)

  • 1. Preparation and biological evaluation of (99m)Tc-labelled phenazine dioxides as potential tracers for hypoxia imaging.
    Fernández S; Berchesi A; Tejeria E; Sanz I; Cerecetto H; González M; Lavaggi ML; Rey A
    Curr Radiopharm; 2015; 8(1):56-61. PubMed ID: 25440318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
    Fernández S; Giglio J; Rey AM; Cerecetto H
    Bioorg Med Chem; 2012 Jul; 20(13):4040-8. PubMed ID: 22658538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
    Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
    J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].
    Qi Y; Li G; Chi X; Du L; Huang K; Zhang H; Huang B
    Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):422-6. PubMed ID: 26182867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of
    Ruan Q; Liu Y; Liao L; Hao J; Jiang Y; Jiang J; Zhang J
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
    Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
    Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling of epirubicin with technetium-99m: Optimization, biodistribution and scintigraphic imaging in tumor bearing mice.
    Hina S; Bokhari TH; Roohi S; Rajoka MI; Sohaib M
    Pak J Pharm Sci; 2018 Mar; 31(2):517-524. PubMed ID: 29618443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
    Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.
    Ballot S; Noiret N; Hindré F; Denizot B; Garin E; Rajerison H; Benoit JP
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):602-7. PubMed ID: 16450136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
    Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
    J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of thiol containing furoxan derivatives as coligands for the preparation of potential bioreductive radiopharmaceuticals.
    Cerecetto H; González M; Onetto S; Risso M; Rey A; Giglio J; León E; León A; Pilatti P; Fernández M
    Arch Pharm (Weinheim); 2006 Feb; 339(2):59-66. PubMed ID: 16470649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biodistribution of NC100668 and the effect of excess NC100668 on the biodistribution and kidney retention of (99m)Tc-NC100668 in the rat.
    Edwards D; Lewis J; Battle M; Lear R; Farrar G; Barnett DJ; Godden V; Edwards C; Oliveira A; Ahlström H
    Nucl Med Biol; 2007 Apr; 34(3):315-23. PubMed ID: 17383581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Fernández S; Dematteis S; Giglio J; Cerecetto H; Rey A
    Nucl Med Biol; 2013 Feb; 40(2):273-9. PubMed ID: 23218939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
    Mallia MB; Mittal S; Sarma HD; Banerjee S
    Bioorg Med Chem Lett; 2016 Jan; 26(1):46-50. PubMed ID: 26615889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia.
    Giglio J; Fernández S; Rey A; Cerecetto H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):394-7. PubMed ID: 21087863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
    Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
    Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
    Maina T; Nikolopoulou A; Stathopoulou E; Galanis AS; Cordopatis P; Nock BA
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1804-14. PubMed ID: 17594090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.